These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36093679)

  • 41. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
    [No Abstract]   [Full Text] [Related]  

  • 43. Risk Factors of Mortality After Liver Transplantation in Uruguay.
    Olivari D; Mainardi V; Rando K; Rey G; Menendez J; Prieto J; Medina J; Valverde M; Castelli J; Grecco G; Leites A; Zunini G; Gozalez S; Harguindeguy M; Gerona S
    Transplant Proc; 2018 Mar; 50(2):499-502. PubMed ID: 29579835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver transplantation in Spain.
    de la Rosa G; Fondevila C; Navasa M
    Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.
    Lombardo-Quezada J; Colmenero J; López-Pelayo H; Gavotti C; Lopez A; Crespo G; Lopez E; Gual A; Lligoña A; Navasa M
    Liver Transpl; 2019 Aug; 25(8):1142-1154. PubMed ID: 30920118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.
    Ramadori G; Bosio P; Moriconi F; Malik IA
    BMC Cancer; 2018 Mar; 18(1):257. PubMed ID: 29510685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of relapse to significant alcohol drinking after liver transplantation.
    Karim Z; Intaraprasong P; Scudamore CH; Erb SR; Soos JG; Cheung E; Cooper P; Buzckowski AK; Chung SW; Steinbrecher UP; Yoshida EM
    Can J Gastroenterol; 2010 Apr; 24(4):245-50. PubMed ID: 20431813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis.
    Serra MA; Escudero A; Rodríguez F; del Olmo JA; Rodrigo JM
    J Clin Gastroenterol; 2003 Feb; 36(2):170-4. PubMed ID: 12544203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation for alcoholic liver disease with or without hepatitis C.
    Goldar-Najafi A; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Int J Surg Pathol; 2002 Apr; 10(2):115-22. PubMed ID: 12075404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.
    N'Kontchou G; Aout M; Laurent A; Nahon P; Ganne-Carrié N; Grando V; Baghad I; Roulot D; Trinchet JC; Sellier N; Cherqui D; Vicaut E; Beaugrand M; Seror O
    J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
    Puigvehí M; Hashim D; Haber PK; Dinani A; Schiano TD; Asgharpour A; Kushner T; Kakked G; Tabrizian P; Schwartz M; Gurakar A; Dieterich D; Boffetta P; Friedman SL; Llovet JM; Saberi B
    Am J Transplant; 2020 Jan; 20(1):220-230. PubMed ID: 31437349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.
    Singal AK; Bashar H; Anand BS; Jampana SC; Singal V; Kuo YF
    Hepatology; 2012 May; 55(5):1398-405. PubMed ID: 22213344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
    Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
    Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.